Abstract
Mutations in copper/zinc superoxide dismutase 1 (SOD1), primary causes of human amyotrophic lateral sclerosis (ALS), provoke motor neuron death through an unidentified toxic property. The known neurofilament–dependent slowing of axonal transport, combined with the prominent misaccumulation of neurofilaments in ALS, suggests that an important aspect of toxicity may arise from damage to transport. Here we verify this hypothesis for two SOD1 mutations linked to familial ALS. Reduced transport of selective cargoes of slow transport, especially tubulin, arises months before neurodegeneration. For one mutant, this represents the earliest detectable abnormality. Thus, damage to the cargoes or machinery of slow transport is an early feature of toxicity mediated by mutant SOD1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Williams, D. B. & Windebank, A. J. Peripheral Neuropathy (eds Dyck, P. J., Thomas, P. K., Griffin, J. W., Low, P. A. & Poduslo, J. F.) 1028–1050 (W.B. Saunders, Philadelphia, 1993).
Rosen, D. R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotropic lateral sclerosis. Nature 362, 59–62 (1993).
Deng, H.–X. et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261, 1047–1051 (1993).
Fridovich, I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64, 97–112 ( 1995).
Halliwell, B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344, 721–724 (1994).
Yu, B. P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74, 139–162 (1994).
Bowling, A. C., Schulz, J. B., Brown, R. H. Jr & Beal, M. F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322–2325 (1993).
Borchelt, D. R. et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 91, 8292– 8296 (1994).
Cleveland, D. W., Laing, N., Hurse, P. V. & Brown, R. H. Toxic mutants in Charcot's sclerosis. Nature 378, 342– 343 (1995).
Reaume, A. B. et al. Motor neurons in Cu/Zn superoxide dismutase–deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13, 43–47 (1996).
Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772–1775 (1994).
Wong, P. C. et al. An adverse property of a familial ALS–linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105–1116 (1995).
Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H. & Gordon, J. W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 92, 689–693 (1995).
Bruijn, L. I. et al. ALS–linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1–containing inclusions. Neuron 18, 327–338 (1997).
Bruijn, L. I. et al. Mutant–SOD1 mediated Amyotrophic Lateral Sclerosis disease onset, progression and pathology is independent of wild–type protein. Science 281, 1851–1854 (1998).
Williamson, T. L. et al. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial ALS–linked SOD1 mutant. Proc. Natl. Acad. Sci. USA 95, 9631 –9636 (1998).
Banker, B.Q. Myology (eds Engel, A. G. & Banker, B. Q.) 2031– 2066 (McGraw–Hill, New York, 1986).
Hirano, A., Donnenfeld, H., Sasaki, S. & Nakano, I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43, 461–470 (1984).
Hirano, A. et al. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43, 471–480 ( 1984).
Shibata, N. et al. Intense superoxide dismutase–1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 55 , 481–490 (1996).
Rouleau, G. A. et al. SOD1 mutation is associated with accumulation of neurofilaments in Amyotrophic Lateral Sclerosis. Ann. Neurol. 39, 128–131 (1996).
Kawamura, Y. et al. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 40, 667– 675 (1981).
Willard, M. & Simon, C. Modulations of neurofilament axonal transport during the development of rabbit retinal ganglion cells. Cell 35, 551–559 ( 1983).
Williamson, T. L. et al. Neurofilaments, radial growth of axons, and mechanisms of motor neuron disease. Cold Spring Harb. Symp. Quant. Biol. 61, 709–723 (1996).
Côté, F., Collard, J. F. & Julien, J. P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73, 35–46 (1993).
Collard, J. F., Côté, F. & Julien, J. P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375, 61–64 (1995).
Hoffman, P. N. & Lasek, R. J. The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons. J. Cell Biol. 66, 351–366 ( 1975).
Hirokawa, N. The mechanisms of fast and slow transport in neurons: identification and characterization of the new kinesin superfamily motors. Curr. Opin. Neurobiol. 7, 605–614 (1997).
Baas, P. W. Microtubules and axonal growth. Curr. Opin. Cell Biol. 9, 29–36 (1997).
Lee, M. K., Rebhun, L. I. & Frankfurter, A. Posttranslational modification of class III beta–tubulin. Proc. Natl. Acad. Sci. USA 87, 7195– 7199 (1990).
Lopata, M. A. & Cleveland, D. W. In vivo microtubules are copolymers of available beta–tubulin isotypes: localization of each of six vertebrate beta–tubulin isotypes using polyclonal antibodies elicited by synthetic peptide antigens. J. Cell Biol. 105, 1707 –1720 (1987).
Borchelt, D. R. et al. Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice. Neurobiol. Dis. 5, 27–35 (1998).
Mitsumoto, H., Kurahashi, K., Jacob, J. M. & McQuarrie, I. G. Retardation of fast axonal transport in wobbler mice. Muscle Nerve 16, 542–547 ( 1993).
Zhang, B., Tu, P., Abtahian, F., Trojanowski, J. Q. & Lee, V. M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol. 139, 1307– 1315 (1997).
Marszalek, J. R. et al. Neurofilament subunit NF–H modulates axonal diameter by selectively slowing neurofilament transport. J. Cell Biol. 135, 711–724 (1996).
Lee, M. K., Marszalek, J. & Cleveland, D. W. Expression of a mutant neurofilament subunit causes massive, selective motor neuron death and ALS–like motor neuron disease. Neuron 13, 975–988 (1994).
Hoffman, P. N., Lasek, R. J., Griffin, J. W. & Price, D. L. Slowing of the axonal transport of neurofilament proteins during development. J. Neurosci. 3, 1694–1700 (1983).
Hoffman, P. N., Griffin, J. W., Gold, B. G. & Price, D. L. Slowing of neurofilament transport and the radial growth of developing nerve fibers. J. Neurosci. 5, 2920– 2929 (1985).
Hoffman, P. N., Thompson, G. W., Griffin, J. W. & Price, D. L. Changes in neurofilament transport coincide temporally with alterations in the caliber of axons in regenerating motor fibers. J. Cell Biol. 101, 1332–1340 ( 1985).
Couillard–Depres, S. et al. Protective effect of neurofilament over–expression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. USA 95, 9626– 9630 (1998).
Corson, L. B., Strain, J. J., Culotta, V. C. & Cleveland, D. W. Chaperone–facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis–linked superoxide dismutase mutants. Proc. Natl. Acad. Sci. USA 95, 6361–6366 (1998).
Xu, Z., Cork, L. C., Griffin, J. W. & Cleveland, D. W. Increased expression of neurofilament subunit NF–L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73, 23–33 ( 1993).
Pardo, C. A. et al. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. USA 92, 954– 958 (1995).
Acknowledgements
We acknowledge Karen L. Anderson, Janet S. Folmer and Scott D. Anderson for technical assistance. This work was supported by grant NS 27036 from the NIH and a grant from the Muscular Dystrophy Association to D.W.C. T.L.W. was supported, in part, by a postdoctoral fellowship from the Muscular Dystrophy Association. Salary support for D.W.C. is provided by the Ludwig Institute for Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Williamson, T., Cleveland, D. Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neurons. Nat Neurosci 2, 50–56 (1999). https://doi.org/10.1038/4553
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/4553
This article is cited by
-
Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy
Journal of Human Genetics (2023)
-
Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1G93A Mice
Neurotherapeutics (2023)
-
Neurofilament accumulations in amyotrophic lateral sclerosis patients’ motor neurons impair axonal initial segment integrity
Cellular and Molecular Life Sciences (2023)
-
Characterization of somatosensory neuron involvement in the SOD1G93A mouse model
Scientific Reports (2022)
-
Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis
Molecular Neurobiology (2022)